Orlando airport gears up for record-breaking holiday travel Elephant orphans. Goat’s milk. This safari reveals the impact of wildlife conservation in Kenya Sloth World plans quiet existence on ...

If you play Pokémon GO, you may have heard about Keldeo — a Mythical Water/Fighting-type Pokémon. Until recently, Keldeo was only available in its “Ordinary” form. But now, thanks to the 2025 season ...

Do you want to change Keldeo into its Resolute Form in Pokémon Go? Follow the guide to know how you can make it happen! We shall see the steps for the same, along with some more ideas. So, let’s begin ...

Like many other parts in Once Human, the way you get standard parts is by using a Disassembly Bench, basically a huge hopper. The catch is that you need to have collected standard items to scrap, and ...

The Election Commission of India (ECI) has initiated the Special Intensive Revision (SIR) process across multiple states, with booth-level officers distributing enumeration forms to electors. The SIR ...

Google is rolling out new AI-powered features to book and plan travel in Search, the company announced on Monday. The tech giant is expanding availability for its AI-powered “Flight Deals” tool, ...

In this video, I travel on SpiceJet, which has a reputation for being one of India's worst airlines, to assess the quality of the service and flying experience. The journey highlights various aspects ...

As they met last week in Washington, delegates to the meeting of the World Bank and International Monetary Fund studiously avoided discussion of one subject: a change in the world’s gold policy.

Dying Light: The Beast makes the act of going from one location to another a challenging experience where you're just as likely to get swarmed by zombies as you are to discover a new hideout bursting ...

This year’s premier football game from EA, EA FC 26, promises to bring major upgrades to so much of what players engage with the most, not to mention evolve decades-long features and modes to bring ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.